Sep. 20, 2024 — Researchers have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumor cells in the dreaded glioblastoma -- at least ...

Study evaluates AI large language model GPT-4 versus human radiologists for diagnosing brain tumors with surprising results.

Brain cancer is a complex and scary disease that affects many people worldwide. Even with advances in medical research, ...

As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that ...

Recent research zooms in on the brain's own 'waste-disposal' system, with the aim of uncovering potential strategies to ...

A common FDA-approved antidepressant shows potential in the cure of glioblastoma, a deadly form of brain cancer.

It was adapted to simultaneously test hundreds of active substances on human cancer tissue. In the current study, they tested 132 existing substances that can cross the blood–brain barrier, including ...

Glioblastoma is a particularly aggressive brain tumor that at present is incurable ... of active substances on living cells from human cancer tissue. Their study focused primarily on neuroactive ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival ... the development of clinical trials with human patients. Glioblastomas carry biological ...

The disruption of abnormal activity in the gut microbiome may increase our risk for neurological disease, research suggests.

A recent study from Osaka Metropolitan University indicates that advanced artificial intelligence (AI) can perform comparably ...

A new study has discovered a method to prevent the spread of cancer to the brain by inhibiting the enzyme IMPDH. Over 500 molecules were evaluated, revealing promising candidates for stopping cancer ...